FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997798769> ?p ?o ?g. }

• W2997798769 endingPage "315" @default.
• W2997798769 startingPage "306" @default.
• W2997798769 abstract "Background: Integrins are crucial anti-cancer therapy targets. We previously showed that tablysin-15 is an integrin antagonist with its Arg-Gly-Asp motif in a novel structural context. Objective: Here we investigated the anti-cancer effects and mechanisms of action of tablysin-15 in melanoma cells. Methods: Cell adhesion, competitive binding, cell viability, and ATP chemiluminescence assays were used to analyze the binding of tablysin-15 to αvβ3 integrin and its phenotypic effects. Wound healing, transwells, and zymography were performed to detect motility and matrix metalloproteinase- 2/-9 activities. PARP and caspase-3 cleavage were used as apoptosis assays, while LDH release and flow cytometry were used for necrosis and cell cycle analysis. The expression of mRNAs and proteins of target molecules was measured by qRT-PCR and western blotting, respectively. Results: Tablysin-15 dose-dependently inhibited the proliferation, migration, and invasion of M21 cells through integrin αvβ3. The proliferation inhibition caused by tablysin-15 was attributable to G0/G1 phase arrest rather than apoptosis or necrosis. Furthermore, tablysin-15 suppressed MMP-2/- 9 activities and the mRNA expression of MMP-2/-9 and COX-2 but was upregulated TIMP-1 in M21 cells. Meanwhile, tablysin-15 suppressed the expression of cyclin D1/E and CDK 2/6, the phosphorylation of FAK, Akt, and ERK, and nuclear translocation of NF-κB, while increasing the expression of the CDK inhibitor p21waf1/C1. Taken together, tablysin-15 might inhibit melanoma cell metastasis and proliferation by competing with αvβ3 integrin, thereby blocking FAK-associated signaling pathways and nuclear translocation of NF-κB. Conclusions: Tablysin-15 has reliable anti-cancer effects against M21 melanoma cells, suggesting tablysin-15 is a promising anti-tumor drug." @default.
• W2997798769 created "2020-01-10" @default.
• W2997798769 creator A5028476850 @default.
• W2997798769 creator A5035915405 @default.
• W2997798769 creator A5050304420 @default.
• W2997798769 creator A5051586443 @default.
• W2997798769 creator A5075290741 @default.
• W2997798769 creator A5078501534 @default.
• W2997798769 creator A5080256378 @default.
• W2997798769 date "2020-04-30" @default.
• W2997798769 modified "2023-10-17" @default.
• W2997798769 title "Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling" @default.
• W2997798769 cites W1969850350 @default.
• W2997798769 cites W1970312745 @default.
• W2997798769 cites W1987228194 @default.
• W2997798769 cites W2009306082 @default.
• W2997798769 cites W2015583071 @default.
• W2997798769 cites W2016963171 @default.
• W2997798769 cites W2050384949 @default.
• W2997798769 cites W2103957625 @default.
• W2997798769 cites W2108398407 @default.
• W2997798769 cites W2115044953 @default.
• W2997798769 cites W2129703339 @default.
• W2997798769 cites W2135461728 @default.
• W2997798769 cites W2167107456 @default.
• W2997798769 cites W2201926879 @default.
• W2997798769 cites W2324999500 @default.
• W2997798769 cites W2325254199 @default.
• W2997798769 cites W2326647919 @default.
• W2997798769 cites W2343895447 @default.
• W2997798769 cites W2346407812 @default.
• W2997798769 cites W2346533286 @default.
• W2997798769 cites W2434776941 @default.
• W2997798769 cites W2493805855 @default.
• W2997798769 cites W2527824850 @default.
• W2997798769 cites W2591139571 @default.
• W2997798769 cites W2600911889 @default.
• W2997798769 cites W2753110021 @default.
• W2997798769 cites W2803738393 @default.
• W2997798769 cites W2808653837 @default.
• W2997798769 cites W2901820061 @default.
• W2997798769 cites W2908582408 @default.
• W2997798769 cites W4213141530 @default.
• W2997798769 doi "https://doi.org/10.2174/1568009620666200101094736" @default.
• W2997798769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31893992" @default.
• W2997798769 hasPublicationYear "2020" @default.
• W2997798769 type Work @default.
• W2997798769 sameAs 2997798769 @default.
• W2997798769 citedByCount "5" @default.
• W2997798769 countsByYear W29977987692020 @default.
• W2997798769 countsByYear W29977987692021 @default.
• W2997798769 crossrefType "journal-article" @default.
• W2997798769 hasAuthorship W2997798769A5028476850 @default.
• W2997798769 hasAuthorship W2997798769A5035915405 @default.
• W2997798769 hasAuthorship W2997798769A5050304420 @default.
• W2997798769 hasAuthorship W2997798769A5051586443 @default.
• W2997798769 hasAuthorship W2997798769A5075290741 @default.
• W2997798769 hasAuthorship W2997798769A5078501534 @default.
• W2997798769 hasAuthorship W2997798769A5080256378 @default.
• W2997798769 hasConcept C121608353 @default.
• W2997798769 hasConcept C1491633281 @default.
• W2997798769 hasConcept C153911025 @default.
• W2997798769 hasConcept C185592680 @default.
• W2997798769 hasConcept C195687474 @default.
• W2997798769 hasConcept C502942594 @default.
• W2997798769 hasConcept C54355233 @default.
• W2997798769 hasConcept C55493867 @default.
• W2997798769 hasConcept C57074206 @default.
• W2997798769 hasConcept C62112901 @default.
• W2997798769 hasConcept C62478195 @default.
• W2997798769 hasConcept C75217442 @default.
• W2997798769 hasConcept C86803240 @default.
• W2997798769 hasConcept C95444343 @default.
• W2997798769 hasConcept C96232424 @default.
• W2997798769 hasConceptScore W2997798769C121608353 @default.
• W2997798769 hasConceptScore W2997798769C1491633281 @default.
• W2997798769 hasConceptScore W2997798769C153911025 @default.
• W2997798769 hasConceptScore W2997798769C185592680 @default.
• W2997798769 hasConceptScore W2997798769C195687474 @default.
• W2997798769 hasConceptScore W2997798769C502942594 @default.
• W2997798769 hasConceptScore W2997798769C54355233 @default.
• W2997798769 hasConceptScore W2997798769C55493867 @default.
• W2997798769 hasConceptScore W2997798769C57074206 @default.
• W2997798769 hasConceptScore W2997798769C62112901 @default.
• W2997798769 hasConceptScore W2997798769C62478195 @default.
• W2997798769 hasConceptScore W2997798769C75217442 @default.
• W2997798769 hasConceptScore W2997798769C86803240 @default.
• W2997798769 hasConceptScore W2997798769C95444343 @default.
• W2997798769 hasConceptScore W2997798769C96232424 @default.
• W2997798769 hasFunder F4320321001 @default.
• W2997798769 hasIssue "4" @default.
• W2997798769 hasLocation W29977987691 @default.
• W2997798769 hasLocation W29977987692 @default.
• W2997798769 hasOpenAccess W2997798769 @default.
• W2997798769 hasPrimaryLocation W29977987691 @default.
• W2997798769 hasRelatedWork W1978760124 @default.
• W2997798769 hasRelatedWork W1993999745 @default.
• W2997798769 hasRelatedWork W2004726042 @default.

• next